Mergers and Acquisitions

* On July 30 2013, Crown Bioscience, a US drug discovery and development service company, has announced that it has acquired the shares of Preclinical Oncology Services Limited (PRECOS), a pre-clinical research and development service provider with a specific focus on oncology. As a result of the acquisition Crown Bioscience becomes the largest supplier of oncology services with a global footprint, spanning three major continents in North America, Europe and Asia Pacific. Headquartered in Santa Clara, the company also has research facilities in Kannapolis, North Carolina (USA), Beijing (China) and Taicang (near Shanghai, China.)

PRECOS has a 15 year pedigree of delivering reproducible, patient-relevant in vivo and in vitro oncology models as a business unit of the University of Nottingham, UK. In 2010 PRECOS became fully independent to provide a solely commercial service to its clients.